Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methyldopa -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - iloprost trometamol - nebuliser liquid - 20microgram/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - ipratropium bromide monohydrate, quantity: 522 microgram (equivalent: ipratropium bromide, qty 500 microgram) - inhalation, conventional - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for moderate asthma attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery; use during assisted ventilation with a respirator.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - ipratropium bromide monohydrate, quantity: 261 microgram (equivalent: ipratropium bromide, qty 250 microgram) - inhalation, conventional - excipient ingredients: water for injections; hydrochloric acid; sodium chloride - for moderate asthma attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery; use during assisted ventilation with a respirator.

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - ipratropium bromide monohydrate, quantity: 522 microgram/ml (equivalent: ipratropium bromide, qty 500 microgram/ml) - inhalation, conventional - excipient ingredients: sodium chloride; hydrochloric acid; purified water - moderate asthmatic attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery, use during assisted ventilation with a respirator. administration of atrovent via a nebuliser is intended for those patients who cannot use a metered dose aerosol.

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - ipratropium bromide monohydrate, quantity: 0.261 mg/ml (equivalent: ipratropium bromide, qty 0.25 mg/ml) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; sodium chloride; hydrochloric acid; disodium edetate - moderate asthmatic attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery, use during assisted ventilation with a respirator. administration of atrovent via a nebuliser is intended for those patients who cannot use a metered dose aerosol.

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - ipratropium bromide monohydrate, quantity: 261 microgram/ml (equivalent: ipratropium bromide, qty 250 microgram/ml) - inhalation, conventional - excipient ingredients: purified water; sodium chloride; hydrochloric acid - moderate asthmatic attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery, use during assisted ventilation with a respirator. administration of atrovent via a nebuliser is intended for those patients who cannot use a metered dose aerosol.

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - budesonide, quantity: 200 microgram/actuation - insufflation - excipient ingredients: - treatment of bronchial asthma. indications as at 3 june 1994: treatment of bronchial asthma. may also be used when replacement or reduction in oral steroid therapy is desired.

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - budesonide, quantity: 400 microgram/actuation - insufflation - excipient ingredients: - treatment of bronchial asthma. indications as at 3 june 1994: treatment of bronchial asthma. may also be used when replacement or reduction in oral steroid therapy is desired.

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - budesonide, quantity: 100 microgram/actuation - insufflation - excipient ingredients: - treatment of bronchial asthma. indications as at 3 june 1994: treatment of bronchial asthma. may also be used when replacement or reduction in oral steroid therapy is desired.